A detailed history of Financial Avengers, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Financial Avengers, Inc. holds 41,688 shares of JNJ stock, worth $6.09 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
41,688
Previous 39,873 4.55%
Holding current value
$6.09 Million
Previous $6.25 Million 5.52%
% of portfolio
1.95%
Previous 3.79%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $281,724 - $295,373
1,815 Added 4.55%
41,688 $6.59 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $45,572 - $49,729
313 Added 0.79%
39,873 $6.25 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $168,054 - $188,263
-1,079 Reduced 2.66%
39,560 $6.16 Million
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $61,894 - $66,610
401 Added 1.0%
40,639 $6.73 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $54,378 - $64,893
360 Added 0.9%
40,238 $6.24 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $2,723 - $3,056
-17 Reduced 0.04%
39,878 $7.04 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $72,275 - $80,424
448 Added 1.14%
39,895 $6.52 Million
Q2 2022

Aug 16, 2022

BUY
$168.19 - $186.01 $36,160 - $39,992
215 Added 0.55%
39,447 $7 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $12,018 - $13,648
76 Added 0.19%
39,232 $6.95 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $37,267 - $41,349
239 Added 0.61%
39,156 $6.7 Million
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $112,242 - $124,731
695 Added 1.82%
38,917 $6.29 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $182,923 - $196,217
1,147 Added 3.09%
38,222 $6.3 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $583,349 - $649,699
3,811 Added 11.46%
37,075 $6.09 Million
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $4.56 Million - $5.24 Million
33,264 New
33,264 $5.24 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Financial Avengers, Inc. Portfolio

Follow Financial Avengers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Avengers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Avengers, Inc. with notifications on news.